简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2025-02-21 10:35 Celltrion Unveils New Post-Hoc Analyses of LIBERTY Studies at the 20th ECCO Congress Further Evaluating the Efficacy and Safety of Subcutaneous (SC) Infliximab
2025-02-20 14:46 Parse Biosciences Launches 5 Million Cell Evercode WT Penta Kit for Single Cell Sequencing
2025-02-20 14:13 Celltrion Expands Biosimilar Portfolio in the European Union Following European Commission Approval of Two Biosimilars
2025-02-19 10:55 Italian Tennis Star Jasmine Paolini Joins Amazfit as Latest Athlete Ambassador
2025-02-19 10:08 Novotech Partners with Wonju Severance Christian Hospital to Drive Clinical Research Excellence in Korea
2025-02-18 16:05 Galderma’s Nemluvio® (Nemolizumab) Granted Marketing Authorization in the United Kingdom and Switzerland for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis
2025-02-18 10:39 ICC Arbitral Tribunal Rules in Favor of AOP Health in Arbitration Proceedings Pertaining to BESREMi® (Ropeginterferon alfa-2b)
2025-02-14 17:34 Galderma’s Nemluvio® (Nemolizumab) Approved in the European Union for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis
2025-02-13 14:58 SBC Medical Group Holdings Announces its Purchase of Bitcoin
2025-02-11 14:38 Zayed Sustainability Prize Opens Global Call for Transformative Solutions
2025-02-11 14:22 PHC and CCRM Collaborate to Develop Primary T-Cell Expansion Culture Processes to Enhance Efficiency and Improve Cell Quality
2025-02-07 10:50 Parse Biosciences Invalidates All 10x Genomics’ Patent Claims Asserted Against Its Products
2025-02-06 15:09 ELIQUENT Life Sciences Announces: Rob Wojciechowski Named Chief Operations Officer
2025-02-06 12:41 Merz Aesthetics Reveals Global Data on the Connection Between Confidence, Self-Affirmation and Aesthetic Treatments
2025-02-06 11:43 GE HealthCare Invests $138 Million in Cork, Ireland Manufacturing Facility to Address Increasing Contrast Media Demand
2025-02-06 11:34 IMCAS 2025: New Galderma Phase IIIb Data Reinforce Rapid Onset and Long-lasting Aesthetic Improvement with RelabotulinumtoxinA (Relfydess™)
2025-02-06 10:52 Ferrer is Recognized for Its Best-in-class Ethics and Compliance Program
2025-02-06 10:35 Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 2026
2025-02-06 10:31 Galderma Demonstrates Injectable Aesthetics Leadership in Medication-Driven Weight Loss With New Research and First International Consensus-Based Guidelines
2025-02-06 10:27 Takeda Delivers Strong Third-Quarter FY2024 Results; Raises Full Year Outlook, Forecasting Revenue and Core Operating Profit Margin Growth

Business Wire Weibo

Press Releases

Latest Releases